Will this submission unlock the starting of the other longtime “planned” trials one by one or does the FDA NDA submission still push this out?
I think further pipeline expansion may be somewhat dependent on whether or not a confirmatory AD trial is required in Europe. And...as you imply, the FDA NDA status is still wide open.